GHRL and depressive symptom measurement: The difference in depression score on the HADS between the groups exceeds the minimum clinically important difference of 1.7 established in patients with cardiovascular disease.37 However, given the potential influence of many other psychosocial factors on depression over a year, it is uncertain how much of the difference can be attributed to the ghrelin intervention.